Cardiovascular disease in women. Why now?;Enfermedades cardiovasculares en la mujer: ¿por qué ahora?

Revista Espanola de Cardiologia

Volumn 59, Issue 3, 2006, Pages 259-263

  Alfonso, Fernando ^a   Bermejo, Javier ^a   Segovia, Javier ^a  

^a Revista Espanola de Cardiologia   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN;

ARTICLE; CARDIOVASCULAR DISEASE; EPIDEMIOLOGICAL DATA; FEMALE; HEALTH CARE ORGANIZATION; HEALTH CARE UTILIZATION; HEALTH PROGRAM; HEART MUSCLE ISCHEMIA; HUMAN; INCIDENCE; INFORMATION PROCESSING; MEDICAL RESEARCH; MORBIDITY; MORTALITY; PREVALENCE; PROGNOSIS; SEX DIFFERENCE; UNITED STATES;

EID: 33646425622     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1157/13086083     Document Type: Article

References (35)

1. American Heart Association. Women and cardiovascular diseases: statistics. Statistical fact sheet-populations [citado Dic 2005). Disponible en: www.americanheart.org/downloadable/heart/ 1109000876764FS10WM05REV.DOC
2. Mosca L, Grundy SM, Judelson D, King K, Limacher M, Oparil S, et al. Guide to preventive cardiology in women. Circulation. 1999;99:2480-4.
3. Mosca L, Appel LJ, Benjamin EJ, Berra Y, Chandra-Strobos N, Fabunmi RP, et al. Evidence-based guidelines for cardiovascular disease prevention in women. Circulation 2004;109:672-93.
4. Mosca L, Ferris A, Fabunmi R, Robertson RM. Tracking women's awareness of heart disease. An American Heart Association National Study. Circulation. 2004;109:573-9.
5. Petersen S, Peto V, Scaborough P, Raymer M, British Heart Foundation Health Promotion Research Group. Coronary Heart Disease Statistics 2005. British Heart Foundation 2005. Disponible en: www.heartstats.org/temp/ CHD_2005_Whole⊃document.pdf
6. Blomkalns AL, Chen AY, Hochman JS, Peterson ED, Trynosky K, Diercks DB, et al. Gender disparities in the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: large scale observations from the CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early implementation of the American College of Cardiology/American Heart Association Guidelines) National Quality Improvement Initiative. J Am Coll Cardiol. 2005;45:832-7.
7. Murga N, Pedreira M, Mazón P, Alonso A. Temas de actualidad en cardiología clínica y extrahospitalaria. Un nuevo proyecto: enfermedad cardiovascular en la mujer. Rev Esp Cardiol. 2006;59 Supl 1:99-104.
8. Stramba-Badiale M, Priori SG. Gender-specific prescription for cardiovascular diseases? Eur Heart J. 2005:26:1571-2.
9. Merz NB, Bonow RO, Sopko G, Balaban RS, Cannon III RO, Gordon D, et al. Women's Ischemic Syndrome Evaluation. Current status and future research directions. Report on the National Heart, Lung and Blood Institute Workshop October 2-4, 2002. Executive summary. Circulation. 2004;109:805-7.
10. Alfonso F, Bermejo J, Segovia J. Revista Española de Cardiología 2005: actividad y reconocimiento científico. Rev Esp Cardiol. 2005;58:1482-7.
11. Ridker PM, Cook NR, Lee IM, Gordon D, Gaziano JM, Manson JE, et al. A randomized trial of low dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med. 2005;352:1293-304.
12. Mieres JH, Shaw LJ, Arai A, Budoff MJ, Flamm SD, Hundley G, et al. Role of non-invasive testing in the clinical evaluation of women with suspected coronary artery disease. Consensus statement from the Cardiac Imaging Committee, Council on Clinical Cardiology, and the Cardiovascular Imaging and Intervention Committee, Council on Cardiovascular Radiology and Intervention, American Heart Association. Circulation. 2005;111:682-96.
13. Lansky AJ, Hochman JS, Ward PA, Mintz GS, Fabunmi R, Berger PB, et al. Percutaneous coronary interventions and adjunctive pharmacotherapy in women. A statement for healthcare professionals from the American Heart Association. Circulation. 2005; 111:940-53.
14. Wallentin L, Lagerqvist B, Husted S, Kontny F, Stahle E, Swahn E. Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary artery disease. The FRISC II invasive randomised trial. Lancet. 2000;356:9-16.
15. Boersma E, Harrington RA, Moliterno DJ, White H, Theroux P, Van de Werf F, et al. Platelet glycoprotein IIbIIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomized clinical trials. Lancet. 2002;359:189-98.
16. Ahumada M, Cabadés A, Valencia J, Cebrián J, Payá E, Morillas P, et al. El reinfarto como complicación del infarto agudo de miocardio. Datos del registro PRIMVAC. Rev Esp Cardiol. 2005:58:13-9.
17. Núñez J, Fácila L, Lácer A, Sanchís J, Bodí V, Bertomeu V, et al. Valor pronóstico del recuento leucocitario en el infarto agudo de miocardio: mortalidad a largo plazo. Rev Esp Cardiol. 2005;58: 631-9.
18. Woodfiled SL, Lundergan CG, Reiner JS. Gender and acute myocardial infarction: is there a different to thrombolysis? J Am Coll Cardiol. 1997;29:35-42.
19. Alfonso F, Macaya C, Iñiguez A, Banuelos C, Rodrigo JL, García Espinosa A, et al. Perfil clínico y resultados de la angioplastia coronaria en mujeres. Comparación con el varón. Rev Esp Cardiol. 1989;42:359-66.
20. Alfonso F, Hernández R, Bañuelos C, Fernández-Ortiz A, Escaned J, Sabate M, et al. Initial results and long-term clinical and angiographic outcome of coronary stenting in women. Am J Cardiol. 2000;86:1380-3.
21. Alfonso F. Restenosis after coronary stenting: the «gender paradox». Eur Heart J. 2003;24:2239.
22. Blankstein R, Ward RP, Arnsdorf F, Jones B, Lou YB, Pine M. Female gender is an independent predictor of operative mortality after coronary artery bypass graft surgery: contemporary analysis of 31 midwestern hospitals. Circulation. 2005;112 Suppl:I323-7.
23. Di Carlo A, Lamassa M, Baldereschi M, Pracucci G, Basile AM, Wolfe CD, et al. Sex differences in the clinical presentation, resource use, and 3-months outcome of acute stroke in Europe. Data from a multicenter, multinational, hospital-based registry. Stroke. 2003;34:1114-9.
24. Ortlepp JR, Schmitz F, Mevissen V, Weiss S, Huster J, Dronskowski R, et al. The amount of calcium-deficient hexagonal hydroxyapatite in aortic valves is influenced by gender and associated with genetic polymorphisms in patients with severe calcific aortic stenosis. Eur Heart J. 2004;25:514-22.
25. Orlowska-Baranowska E, Placha G, Gaciong Z, Baranowski R, Zakrzewski D, Michalek P, et al. Influence of ACE I/D genotypes on left ventricular hypertrophy in aortic stenosis: gender-related differences. J Heart Valve Dis. 2004;13:574-81.
26. Carroll JD, Carroll EP, Feldman T, Ward DM, Lang RM, McGaughey D, et al. Sex-associated differences in left ventricular function in aortic stenosis in the elderly. Circulation. 1992;86: 1099-107.
27. Roberts WC, Ko JM. Relation of weights of operatively excised stenotic aortic valves to preoperative transvalvular peak systolic pressure gradients and to calculated aortic valve areas. J Am Coll Cardiol 2004;44:1847-55.
28. Swedberg K, Cleland J, Dargie H, Drexler H, Follath F, Komajda M, et al. Guías de práctica clínica sobre el diagnóstico y tratamiento de la insuficiencia cardiaca crónica. Versión resumida (actualización 2005). Rev Esp Cardiol. 2005;58:1062-92.
29. Sheppard R, Behlouli H, Richard H, Pilote L. Effect of gender on treatment, resource utilization, and outcomes in congestive heart failure in Quebec, Canada. Am J Cardiol. 2005;95:955-9.
30. Komajda M, Follath F, Swedberg K, Cleland J, Aguilar JC, Cohen-Solal A, et al. The EuroHeart Failure Survey programme-a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment. Eur Heart J 2003;24:464-74.
31. Olivotto I, Maron MS, Adabag AS, Casey SA, Vargiu D, Link MS, et al. Gender-related differences in the clinical presentation and outcome of hypertrophic cardiomyopathy. J Am Coll Cardiol. 2005;46:480-7.
32. Kannel WB, Wilson PWF, D'Agostino RB, Cobb J. Sudden coronary death in women. Am Heart J. 1998;136:205-12.
33. Albert CM, Chae CA, Grodstein F, Rose LM, Rexrode KM, Ruskin JN, et al. Prospective study of sudden cardiac death among women in the United States. Circulation. 2003;107:2096-101.
34. Lessmeier TJ, Gamperling D, Johnson-Liddon V, Fromm BS, Steinman RT, Meissner MD, et al. Unrecognized paroxismal supraventricular tachycardia. Potential for misdiagnosis as panic disorder. Arch Intern Med. 1997;157:537-43.
35. Dagres N, Clague JR, Breithardt G, Borggrefe M. Significant gender-related differences in radiofrequency catheter ablation therapy. J Am Coll Cardiol. 2003;42:1103-7.